Overview

The National Health (Originator Brand) Amendment Determination (June Update) 2026 is a technical amendment to the National Health (Originator Brand) Determination 2025 (PB 114 of 2025). It is administered by the Department of Health, Disability and Ageing under the National Health Act 1953.

What the parent instrument covers

The parent determination sets out the listing and pricing rules for originator brand medicines on the Pharmaceutical Benefits Scheme (PBS).

What this amendment does

The amendment makes changes via Schedule 1 to the parent instrument. The source does not specify what particular changes are made to the schedule beyond identifying the parent instrument being amended. The explanatory statement available on the legislation register page provides detail on the specific schedule changes.

Key dates

Where to find more information

The full legislative instrument is available at https://www.legislation.gov.au/F2026L00645. The explanatory statement on the same page sets out the detail of specific schedule changes made.

This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.